Overview

Step-up Yellow Zone Inhaled Corticosteroids to Prevent Exacerbations

Status:
Completed
Trial end date:
2017-04-21
Target enrollment:
Participant gender:
Summary
The objective of this study is to determine whether, in children receiving low-dose inhaled corticosteroids (ICS), quintupling the dose of inhaled corticosteroids at the onset of symptoms previously associated with upper respiratory illnesses and subsequent asthma exacerbations reduces the rate of severe asthma exacerbations treated with oral corticosteroids.
Phase:
Phase 3
Details
Lead Sponsor:
Milton S. Hershey Medical Center
Treatments:
Fluticasone
Xhance